Insmed Q3 revenue tops $524 million; Brinsupri, Arikayce guidance raised, Japan launch underwayNov 10M&AamikacinbrensocatibUpdated
Insmed registers Phase 1 trial on brensocatib's effect on midazolam metabolismOct 5Trial updatebrensocatibInsmed Incorporated
Insmed raises BRINSUPRI guidance and combined peak sales estimate to over $14 billionAug 6Quarterly updatebrensocatibInsmed Incorporated